VP
Schedule 13G filing
Vanguard Portfolio Management LLC cut its RCKT stake below 5%
Vanguard Portfolio Management LLC reported owning 1.3% of Rocket Pharmaceuticals, Inc. (RCKT) (1,463,677 shares) in a Schedule 13G filed Oct 30, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 30, 2026
- Source
- Schedule 13G
More RCKT insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.